MedPath

The HAA (Herehere and Aukati) Trial: A traditional Maori method of restriction repurposed for indigenous smoking cessation.

Not Applicable
Completed
Conditions
Tobacco Use
Public Health - Health service research
Mental Health - Addiction
Registration Number
ACTRN12616000297426
Lead Sponsor
Tuakana Teina Insight
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
227
Inclusion Criteria

In this trial, the inclusion criteria will include self-identified Maaori who self- identify as current smokers with an inhaled carbon monoxide machine reading of greater than or equal to 4ppm , aged 16 years or over (Perkins, Karlitz & Jao, 2013). Participants will be required to also complete the Fagerstrom Test for Dependence (Heatherton, et al., 1991). The score must be equal to or greater than 5 for enrolement. Smokers must be seeking support to stop smoking and agree to the set a quit date as per their allocated group guidelines.
Pregnant and breastfeeding women can and will be included in this study as will people with severe illness, mental health, and drug and alcohol addictions. Participants must be willing and able to provide consent, understand their role as a participant in the study and willing to comply with study procedures

Exclusion Criteria

People that were unable or unwilling to provide their own informed consent for their participation, non-smokers with a reading of less than 4 ppm, under the age of 16 years old and non-Maaori will be excluded from participating in the trial. People unable to agree to setting a target quit day according to whatever group they are allocated to will be excluded also.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome for the trial is the proportion of smokers with self- reported and verified biochemical continuous abstinence at 12 weeks from the quit date. Abstinence will be defined by using the Russell Standard (that is: intention to treat analysis, only have smoked (if any) a total of five cigarettes from the quit date and biochemical verification of self-reported abstinence through an exhaled carbon monoxide device with a reading of less than 10 ppm (parts per million) [12 weeks abstinence]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath